Blome James 4
4 · Calyxt, Inc. · Filed Oct 10, 2018
Insider Transaction Report
Form 4
Calyxt, Inc.CLXT
Blome James
Chief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
2018-10-08+200,000→ 200,000 totalExercise: $14.24Exp: 2028-10-08→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]The Stock Option was granted on October 8, 2018 and vests 15% on October 8, 2019 and 15% on October 8, 2020, with the remainder vesting quarterly (commencing with the first fiscal quarter of 2021) in equal installments over 42 months.